31.685  -1.38 (-4.17%)		10-10 15:59
Open: 33.04 High: 33.04 Volume: 9,626		Pre. Close: 33.065 Low: 31.668 Market Cap: 49(M)

Short term
Mid term
Targets	6-month :	38.08	1-year :	39.23
Resists	First :	32.6	Second :	33.59
Pivot price	32.33
Supports	First :	31.01	Second :	25.8
MAs	MA(5) :	32.81	MA(20) :	32.31
	MA(100) :	31.74	MA(250) :	30.83
MACD	MACD :	0.2	Signal :	0.2
%K %D	K(14,3) :	69.4	D(3) :	79.8
RSI	RSI(14): 45.5
52-week	High :	35.72	Low :	24.47

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HEAL ] has closed above bottom band by 27.5%. Bollinger Bands are 20.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	33.45 - 33.63	33.63 - 33.78
Low:	32.53 - 32.73	32.73 - 32.9
Close:	32.74 - 33.08	33.08 - 33.37

HEAL aims to focus on tech-driven innovation in the healthcare sector. As such, the fund seeks to provide exposure to firms looking to shape the future of healthcare by improving patient outcomes and driving medical breakthroughs. Companies around the world, including ADRS, that engage in healthcare analytics and software, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer healthcare. The underlying index screens for companies that are found in FactSet industries identified by the index administrator as relating to healthcare technology and derive at least 50% of their revenue from one or more of the subthemes. Prior to April 1, 2025, the fund tracked a narrower index targeting telemedicine and digital health, the Solactive Telemedicine & Digital Health Index. The fund name was Global X Telemedicine & Digital Health ETF and traded using the ticker EDOC.

Thu, 18 Sep 2025
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs - Benzinga

Wed, 10 Sep 2025
Investing in the Future of Healthcare - ETF Trends

Mon, 25 Aug 2025
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers - Benzinga

Thu, 21 Aug 2025
The Next Big Theme: August 2025 - Global X ETFs

Mon, 18 Aug 2025
Global X Announces Five ETF Reverse Stock Splits - PR Newswire

Wed, 30 Jul 2025
The Next Big Theme: July 2025 - Global X ETFs

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.